The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 20, 2026
Filed:
Jul. 01, 2020
Applicant:
Lead Pharma Holding B.v., Oss, NL;
Inventors:
Jaap Gerardus Henricus Lemmers, Oss, NL;
Eugen Deretey, Oss, NL;
Johannes Petrus Gerardus Klomp, Oss, NL;
Joseph Maria Gerardus Barbara Cals, Oss, NL;
Arthur Oubrie, Oss, NL;
Assignee:
LEAD PHARMA HOLDING B.V., Oss, NL;
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/437 (2006.01); A61K 31/4365 (2006.01); A61K 31/444 (2006.01); A61K 31/4709 (2006.01); A61K 31/4725 (2006.01); A61K 31/506 (2006.01); A61P 3/10 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); C07D 471/04 (2006.01); C07D 495/04 (2006.01); C07D 513/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/437 (2013.01); A61K 31/4365 (2013.01); A61K 31/444 (2013.01); A61K 31/4709 (2013.01); A61K 31/4725 (2013.01); A61K 31/506 (2013.01); A61P 3/10 (2018.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); C07D 471/04 (2013.01); C07D 495/04 (2013.01); C07D 513/04 (2013.01);
Abstract
The present invention is directed to compounds according to Formula I and the pharmaceutically acceptable salts thereof. The compounds can be used as modulators of Estrogen-related Receptor alpha (ERRα) and have utility in the treatment of ERRα-mediated diseases or conditions.